Clinical trials
Xerostomia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidad de Granada | 3 |
| University of Santiago de Compostela | 3 |
| Universidad de Murcia | 2 |
| University of Barcelona | 2 |
| Fundacio Salut i Envelliment UAB | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 1 |
| Lacer S.A. | 1 |
| Novartis Pharmaceuticals | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xerostomia | 17 |
| Head and Neck Neoplasms | 4 |
| Salivary Gland Diseases | 4 |
| Autoimmune Diseases | 3 |
| Dry Eye Syndromes | 3 |
| Arthritis | 2 |
| Immune System Diseases | 2 |
| Joint Diseases | 2 |
| Mouth Diseases | 2 |
| Neoplasms | 2 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.